Export Compliance Daily is a service of Warren Communications News.
Subscriber Login
Customs
to
Refine Category Search
Clear Terms

Search Primer

Term list: Separate terms with spaces, not commas or semicolons.

Multi-word term: Place inside quotes to ensure an exact match (e.g. "China import").

Acronyms: Use all capital letters to ensure the search is not looking for that letter sequence instead.

Required term: If a term must be included in any resulting articles, prefix it with a plus sign (e.g., +CBP).

Excluded term: If a term should be excluded from any articles being found, prefix it with a minus sign (e.g., -ruling).

Singular form: Always use the singular form when doing multi-word terms (e.g. "russian export control" instead of "russian export controls").

Shortest word form: When you have different word forms in a quoted (multi-word) term, you want to only include the shortest version if it is the last part of the expression (e.g., "entity list" instead of "entity listing" or "entity listed").

CBP AD and CV Messages as of May 6
May 7, 2020 |Customs

A listing of recent antidumping and countervailing duty messages from the Commerce Department posted to CBP's website May 6 along with the case number(s) and CBP message number, is provided below. The messages are available by searching for the listed CBP message number at CBP's ADD CVD Search page.

ICE Working With Healthcare, E-Commerce Companies to Fight COVID-19 Scams
May 6, 2020 |Customs

The Homeland Security Investigations unit within ICE is working with multiple healthcare and e-commerce companies to fight fraudsters that are trying to take advantage of the COVID-19 pandemic, ICE said in a news release. “Since the start of the pandemic, HSI and other law enforcement agencies have seen a significant increase in criminals attempting to capitalize and profit from the fear and anxiety surrounding the virus, including the sale of counterfeit pharmaceuticals and medical equipment and illicit online sales and trade importation violations of products claiming to be treatment options,” it said. The partnership involves industry experts from Pfizer, 3M, Citi, Alibaba, Amazon and Merck, it said.